Clinical trial
A Study in Pediatric Patients With Cystic Fibrosis Lung Disease
NCT00130182 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00130182 |
|---|---|
| Title | A Study in Pediatric Patients With Cystic Fibrosis Lung Disease |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Pediatric Patients With Cystic Fibrosis Lung Disease |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) |
| Enrollment | 13 |
| Start date | Aug 1, 2005 |
| Primary completion | Sep 1, 2006 |
| First posted | Aug 15, 2005 |
| Last update posted | May 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: